Journal Guide

Aims Alcoholism: Clinical & Experimental Research's aims are:

Alcoholism Treatment Quarterly is an exciting professional journal for clinicians working with persons who are alcoholic and their families. Designed to bridge the gap between research journals and information for the general public, it addresses the specific concerns of professional alcoholism counselors, social workers, psychologists, physicians, clergy, nurses, employee assistance professionals, and others who provide direct services to persons who are alcoholic.The journal features articles specifically related to the treatment of alcoholism, highlighting new and innovative approaches to care, describing clinical problems and solutions, and detailing practical, unique approaches to intervention and therapy. Original research and articles about theory development and policy issues in alcoholism are included. Alcoholism Treatment Quarterly particularly welcomes material giving the personal and humanistic aspects of professional alcoholism counseling and therapy from both the counselor/therapist's view as well as that of the client.The journal explores the 8216;how-to' approaches of intervention and therapy by presenting case studies and commentaries by counselors and therapists. Alcoholism Treatment Quarterly publishes original research and articles related to theory development, emphasizes the art as well as the science inherent in the treatment of alcoholism, serves as a vehicle to integrate diverse approaches and perspectives in the field, advocates the recognition of special treatment needs of alcoholic clients and their families, enhances professionalism in the field of counseling and therapy, and promotes the quality of treatment provided to the alcoholic and his/her family in all domains of the recovery process Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

The Alexandria Journal of Medicine is an international peer reviewed journal, concerned with providing a venue for publication of all aspects of human diseases including basic and clinical aspects with a particular focus on diseases of high prevalence in the Middle East and its comparison to their profile in the rest of the world. Manuscripts from other world regions are welcome, to increase the scientific exchange between the different world regions. Such an exchange would increase the opportunities for international collaborative research, especially that there is a broad range of readers from the region and worldwide.

Towards this end, the AJME publishes original research articles, review articles, short communications, clinical trials in an open access format. For a detailed description of the different types of manuscripts, the readers can consult the online guide for authors. The material is subject to editorial revision. Papers describing research involving human subjects and the procedures followed should be in accordance with the ethical standards. Articles containing promotional material (advertisements), whether implicit or explicit will not be included in the Journal.

Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology. The journal accepts original papers and systematic reviews concerned with clinical gastroenterology, hepatology and endoscopy. AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.

Allergologia et immunopathologia, incluida en Mediline y EMBASE, es una de las publicaciones más prestigiosas entre los especialistas en alergología y aparato respiratorio. Actualmente es el Órgano Oficial de difusión de la Sociedad Española de Inmunología Clínica y Alergología Pediátrica, que comunica todas sus actividades mediante este medio.6 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/ai

Allergology International is the official English language journal of the Japanese Society of Allergology, publishing peer-reviewed articles of scientific excellence in human and experimental allergology, and related fields of research. The Journal aims to further the international exchange of results and encourages authors from all countries to submit papers in the following categories: Original Articles; Case Reports; Short Communications; Occasional Reviews and Editorials; and Letters to the Editor. Allergology International is supported by a Grant-in-Aid for Publication of Scientific Research Result from the Japan Society for the Promotion of Science.

The aim of the journal is to promote and maintain contact between basic and clinical allergy and immunology. Allergy is an international journal with contributors and readers in all countries. Articles are accepted purely on the basis of quality. The journal publishes original articles, reviews, position papers, and short communications (AllergyNet). Original articles of special interest are accompanied by editorial comments. Correspondence to recently published work is also considered.

The official journal of the Canadian Society of Allergy and Clinical Immunology. Allergy, Asthma & Clinical Immunology encompasses all aspects of treatment of allergic and immunologic disease.

ALTER is a peer-reviewed European journal which looks at disability and its variations. It is aimed at everyone who is involved or interested in this field. ALTER is an emblematic Latin word for all forms of difference, leaving open the question of their nature and expression.An inter-disciplinary journalFirst and foremost, interdisciplinarity means remaining open to all human and social sciences: sociology, anthropology, psychology, psychoanalysis, history, demography, epidemiology, economics, law, etc. It also means a connection between the different forms of knowledge - academic and fundamental - applied and relating to the experience of disability.A cross-disciplinary journal Research on disability and its variations constitutes a transversal axis which opens the review up to a multitude of approaches and problematic. It covers matters ranging from the individual to the environment, from impairment to participation, from discrimination to the exercise of citizenship... ALTER looks at all the questions examined in human and social sciences, be they social, economic, political or health related.A European journal The European dimension means having a multicultural outlook; it means well-argued comparisons and useful scientific controversies that go beyond national boundaries.

By applying the most advanced information technologies, Frontiers is catapulting scholarly publishing into a new digital academic era. .

Alzheimer Disease and Associated Disorders is a leading international forum for reports of new research findings and new approaches to diagnosis and treatment. Contributions fall within all relevant scientific fields and clinical specialties, including neurobiology, neurochemistry, molecular biology, neurology, neuropathology, neuropsychology, psychiatry, gerontology, and geriatrics. Rigorous peer review of articles is ensured by an international Editorial Advisory Board of eminent scientists and clinicians. Website: www.alzheimerjournal.com.

The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.

Given the growing number of specialized manuscripts in the field of Alzheimer's and dementia research, DADM will provide an expanded platform to provide a) rapid communication and publication that facilitate cross-fertilization of ideas, b) integrating and translating knowledge across disciplines; disseminating basic and clinical information necessary for optimal translation of research into practical applications and interventions, c) increase knowledge in diverse areas of studies with potentials/implications for practical application related to early detection and/or interventions, d) formulating crucial experiments necessary for the rigorous testing of theories or their predictions, and e) identifying promising new directions of research and providing the impetus or the scientific foundation for new initiatives on interventions.

The mission of Alzheimer's & Dementia: Journal of the Alzheimer's Association is to bridge the knowledge gaps across a wide range of bench-to-bedside investigation. The journal publishes the results of studies in: behavior, biochemistry, genetics, molecular biology, pharmacology, physiology, protein chemistry, neurology, neuropathology, psychiatry, geriatrics, neuropsychology, epidemiology, sociology, health services research, health economics, political science and public policy. Content emphasizes interdisciplinary investigations, integrative/translational articles, related to: etiology, risk factors, early detection, disease modifying interventions, prevention of dementia and applications of new technologies in health services. The journal publishes • comprehensive reviews; • research articles; • information on clinical trials; • short reports;• in-depth perspectives/open-peer commentaries; • theoretical and/or translational papers that attempt integrate knowledge across discipline;• history & politics of science/brief biographies and, • abstracts of papers presented at international meetings. Negative results, particularly clinical trials, are published as short communications.The ultimate objective is to create a novel forum for: • rapid communication of new findings, ideas or perspectives; • disseminating knowledge, across the spectrum of basic to clinical studies, necessary for optimal translation of research findings into practical applications/interventions; • integrating knowledge across disciplines; • increase knowledge in diverse disciplines to promote early detection/diagnosis and/or interventions; • formulating new theories and/or strategies for the rigorous testing of theories or their predictions; • identifying promising new directions of research and, • providing the scientific impetus for new initiatives; or public policies concerning research on prevention and new models of health services.Alzheimer's & Dementia is indexed/abstracted in Index Medicus/MEDLINE, Scopus, Science Citation Index Expanded (SciSearch®), Current Contents®/Clinical Medicine, Neuroscience Citation Index®, and Journal Citation Reports/Science Edition.

Alzheimer's & Dementia: Translational Research & Clinical Interventions (TRCI) is an open access, peer-reviewed, journal from the Alzheimer's Association® that covers translational research and clinical therapeutics for Alzheimer's disease, dementia and other age-related conditions affecting cognition, memory, and behavior. The journal will provide a rapid method for communication among a multidisciplinary clinical research audience involving the range of therapeutic interventions (e.g., drugs, biologicals, devices, and psychotherapeutic, psychosocial, and non-pharmacological modalities) from preclinical development to late stage trials and health technology assessment.

The focus is original, feature length research articles, systematic reviews, metaanalyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that advance the prevention and treatment of Alzheimer's disease, dementia, and cognitive impairment. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurology, psychiatry, clinical psychology, bioinformatics, and health policy as they apply to preclinical and clinical therapeutics. It will focus on discovery, therapeutic development, clinical pharmacology, preclinical studies, and the application of neuropsychology, clinical ratings, clinical trials methods, neuroimaging, biomarkers, clinical research informatics, and other interdisciplinary approaches to clinical therapeutics and outcomes.

Given the growing number of specialized manuscripts in the field of Alzheimer's and dementia research, TRCI provides an expanded platform for the publication of clinical translational research. TRCI encourages the submission of manuscripts that describe preclinical research with a potential for clinical application, research from early human experimentation (experimental medicine) that may advance clinical treatment and prevention of Alzheimer pathology, neurodegeneration, and cognitive impairment.

Like Alzheimer's & Dementia, TRCI will publish manuscripts describing public health research with the potential for application for disease prevention or clinical therapeutics that bridges the laboratory and clinical settings, and laboratory studies of novel therapeutic interventions and new treatment paradigms. Expanding on the growing number of submissions to Alzheimer's & Dementia, TRCI will provide a rapid communication vehicle for manuscripts that focus on translation and clinical research methods, procedures, protocols, analytical approaches and regulatory science.

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

AMBIO addresses the scientific, social, economic, and cultural factors that influence the condition of the human environment. AMBIO particularly encourages multi- or inter-disciplinary submissions with explicit management or policy recommendations. Papers published in AMBIO fall into four main categories:
Report, Review, Perspective, Comment. Regardless of article category, your submission should have a clear link between anthropogenic activities and the environment, or vice versa.For more than 40 years AMBIO has brought international perspective to important developments in environmental research, policy and related activities for an international readership of specialists, generalists, students, decision-makers and interested laymen.  The broad scope of coverage extends to ecology, environmental economics, geology, geochemistry, geophysics, paleontology, hydrology, water resources, oceanography, earth sciences, meteorology, and physical geography.  Authors are advised to check our latest guideline